This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
Public Exchange Woes Hit Health Insurers: Stocks in Focus
by Zacks Equity Research
The U.S private health insurers have been incurring mounting losses from the health insurance marketplace. This has led many of them to pull back participation, worsening the scenario for underprivileged Americans.
Inovalon Holdings' ONE Platform Chosen by UnitedHealthcare
by Zacks Equity Research
Inovalon Holding (INOV) will be able to expand in the population health management space through the selection of its proprietary ONE Platform by UnitedHealthcare.
UnitedHealth (UNH) Scales a 52-Week High on Recent Deals
by Zacks Equity Research
UnitedHealth's (UNH) shares are riding on its recent acquisition announcements.
Cigna Shares (CI) Up 38% This Year: Is Further Upside Left?
by Zacks Equity Research
A mix of factors, ranging from industry to company-specific, are favoring the stock of Cigna (CI), driving solid returns.
UnitedHealth to Buy Advisory Board's Health Care Business
by Zacks Equity Research
The acquisition of Advisory Board's health care business will bolster UnitedHealth's (UNH) health management business.
Humana (HUM) Hits 52-Week High on Solid Q2, Raised Outlook
by Zacks Equity Research
Humana's (HUM) shares have been favored by its strong earnings performance, guidance raise and completion of accelerated share buyback.
UnitedHealth (UNH) Up 2.4% Since Earnings Report: Can It Continue?
by Zacks Equity Research
UnitedHealth (UNH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
UnitedHealth Appoints New CEO, Hemsley Takes On New Role
by Zacks Equity Research
UnitedHealth (UNH) promotes internal candidate to the role of new CEO. Current CEO assumes new responsibility.
Envision Healthcare (EVHC) Q2 Earnings Beat, '17 View Cut
by Zacks Equity Research
Envision Healthcare's (EVHC) strong second-quarter earnings were driven by revenue growth in the Physician Services segment, partly offset by an increase in operating expenses.
Select Medical (SEM) Q2 Earnings Top Estimates, Revises View
by Zacks Equity Research
Select Medical's (SEM) solid Q2 results were driven by the strong performance of all segments.
WellCare Health (WCG) Beats on Q2 Earnings and Revenues
by Zacks Equity Research
Wellcare Health (WCG) reported strong results in the second quarter supported by solid performance across its all three business lines and the acquisitions of Universal American and Care1st Arizona
The Ensign Group (ENSG) Q2 Earnings Miss Estimates, Up Y/Y
by Zacks Equity Research
The Ensign Group's (ENSG) second-quarter earnings missed expectations owing to higher expenses.
Aetna (AET) Tops Q2 Earnings, Revenues, Raises 2017 Guidance
by Zacks Equity Research
Aetna's (AET) strong second-quarter 2017 results were largely driven by improved expense ratio.
Teladoc (TDOC) Q2 Loss Wider than Expected, Revenues Up Y/Y
by Zacks Equity Research
Teladoc's (TDOC) second-quarter loss was wider than expected due to higher expenses.
Molina Healthcare (MOH) Incurs Loss in Q2, Revenues Beat
by Zacks Equity Research
Molina Healthcare (MOH) incurred loss in the second-quarter 2017 owing to higher medical care costs.
Community Health (CYH) Q2 Loss Narrower than Expected (Revised)
by Zacks Equity Research
Community Health's (CYH) second-quarter loss was narrower than expected on lower expenses.
Humana (HUM) Beats Earnings Estimates, Lags Revenues in Q2
by Zacks Equity Research
Humana's (HUM) second-quarter earnings were driven by higher revenues.
LifePoint Health (LPNT) Q2 Earnings Beat Estimates, Up Y/Y
by Zacks Equity Research
LifePoint Health's (LPNT) second-quarter earnings were driven by lower expenses.
Community Health Systems (CYH) Beats Q2 Earnings Estimates
by Zacks Equity Research
Community Health 's (CYH) second-quarter earnings were driven by lower expenses.
The Zacks Analyst Blog Highlights: Bank of America, UnitedHealth, Intel, UPS and Celgene
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Bank of America, UnitedHealth, Intel, UPS and Celgene
Acadia Healthcare (ACHC) Tops Q2 Earnings, Revises View
by Zacks Equity Research
Acadia Healthcare's (ACHC) second-quarter results were boosted by significant revenue growth.
Zacks.com featured highlights: East West Bancorp, UnitedHealth Group, CBRE Group and Hasbro
by Zacks Equity Research
Zacks.com featured highlights: East West Bancorp, UnitedHealth Group, CBRE Group and Hasbro
Anthem (ANTM) Beats Q2 Earnings, Revenues Lag Estimates
by Zacks Equity Research
Anthem's (ANTM) strong second-quarter results were mainly driven by significant rise in medical enrollment, which aided revenue growth.
4 GARP Stocks to Buy for Stellar Returns
by Zacks Equity Research
The GARP approach prefers stocks that are priced below the market or any reasonable target determined by fundamental analysis.
Universal Health (UHS) Q2 Earnings & Revenues Lag Estimates
by Zacks Equity Research
Universal Health's (UHS) lagged second-quarter earnings primarily due to lower revenues and higher expenses.